Literature DB >> 27226515

Sexual Function in Cancer Survivors: Updates to the NCCN Guidelines for Survivorship.

Michelle E Melisko1, Joseph B Narus1.   

Abstract

By the year 2024, predictions estimate that there will be approximately 19 million cancer survivors in the United States, many of whom will experience the physical and/or psychosocial long-term effects of cancer and its treatment. Although sexual dysfunction is common among these individuals, causing increased distress and negatively impacting quality of life, this critical part of survivorship care is often underrecognized and undertreated. At the NCCN 21st Annual Conference, Drs. Melisko and Narus reviewed the sexual function recommendations in the NCCN Guidelines for Survivorship, offering practical strategies for assessing and managing both female and male sexual dysfunction.
Copyright © 2016 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2016        PMID: 27226515     DOI: 10.6004/jnccn.2016.0193

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  3 in total

1.  Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors.

Authors:  Michelle Peate; Christobel Saunders; Paul Cohen; Martha Hickey
Journal:  Breast Cancer Res Treat       Date:  2021-02-11       Impact factor: 4.872

2.  Translation and validation of Persian version of sexual function: vaginal changes questionnaire (SVQ) for women with gynecologic cancers.

Authors:  Raziyeh Maasoumi; Farinaz Rahimi; Somayyeh Naghizadeh
Journal:  BMC Womens Health       Date:  2022-07-08       Impact factor: 2.742

3.  Psychosexual Functioning of Female Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort Study.

Authors:  Kari L Bjornard; Carrie R Howell; James L Klosky; Wassim Chemaitilly; Deo Kumar Srivastava; Tara M Brinkman; Daniel M Green; Victoria W Willard; Lisa M Jacola; Matthew J Krasin; Melissa M Hudson; Leslie L Robison; Kirsten K Ness
Journal:  J Sex Med       Date:  2020-07-25       Impact factor: 3.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.